ExodusPoint Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-297,458
| Closed | -$904K | – | 1982 |
|
|
2024
Q4 | $904K | Buy |
297,458
+172,458
| +138% | +$524K | 0.01% | 889 |
|
|
2024
Q3 | $649K | Sell |
125,000
-316,584
| -72% | -$1.64M | ﹤0.01% | 1042 |
|
|
2024
Q2 | $1.14M | Buy |
+441,584
| New | +$1.14M | 0.01% | 865 |
|
|
2023
Q3 | – | Sell |
-27,345
| Closed | -$692K | – | 2151 |
|
|
2023
Q2 | $692K | Buy |
+27,345
| New | +$692K | 0.01% | 1149 |
|
|
2022
Q3 | – | Sell |
-71,966
| Closed | -$995K | – | 2322 |
|
|
2022
Q2 | $995K | Buy |
+71,966
| New | +$995K | 0.01% | 1034 |
|
|
2022
Q1 | – | Sell |
-44,037
| Closed | -$719K | – | 2685 |
|
|
2021
Q4 | $719K | Buy |
44,037
+12,565
| +40% | +$205K | 0.01% | 1200 |
|
|
2021
Q3 | $877K | Sell |
31,472
-778
| -2% | -$21.7K | 0.01% | 1041 |
|
|
2021
Q2 | $956K | Sell |
32,250
-69
| -0.2% | -$2.05K | 0.01% | 972 |
|
|
2021
Q1 | $903K | Buy |
32,319
+15,812
| +96% | +$442K | 0.01% | 937 |
|
|
2020
Q4 | $468K | Sell |
16,507
-69,152
| -81% | -$1.96M | ﹤0.01% | 1220 |
|
|
2020
Q3 | $2.15M | Buy |
85,659
+36,263
| +73% | +$911K | 0.04% | 342 |
|
|
2020
Q2 | $1.21M | Buy |
+49,396
| New | +$1.21M | 0.03% | 630 |
|
|
2020
Q1 | – | Sell |
-11,765
| Closed | -$191K | – | 1677 |
|
|
2019
Q4 | $191K | Buy |
+11,765
| New | +$191K | ﹤0.01% | 1293 |
|